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Blood pressure (BP) tracking from childhood to adulthood has two aspects: the ranking stability relative to others over time
and the prediction of future values. This study investigates BP tracking in children and adolescents in Germany in the context
of hypertension risk factors. BP was measured and analyzed in 2542 participants of the German Health Examination Survey for
Children and Adolescents (t
0
2003-2006; 3 to 17-year olds) and of a six year follow-up “Motorik Modul” (t
1
2009-2012; 9 to 24-year
olds). BP tracking coefficients were calculated from Spearman’s rank-order correlations. Predictive values and logistic regression
modelswere used to forecast t
1
-BP above the hypertension threshold from t
0
-BP aswell as frombaseline and follow-up hypertension
risk factors. BP tracking wasmoderate (0.33-0.50 for SBP and 0.19-0.39 for DBP) with no statistically significant differences between
sex and age groups. Baseline hypertensive BP was the strongest independent predictor of hypertensive BP at follow-up (OR 4.3 and
3.4 for age groups 3-10 and 11-17 years) after adjusting for sex, BMI trajectories, birthweight, parental hypertension, and age-group
dependent-sports/physical activity.However, the positive predictive value of baseline hypertensive BP for hypertensive BP at follow-
up in 3- to 10-year olds was only 39% (34% in 11- to 17-year olds) and increased only moderately in the presence of additional risk
factors. Our analysis with population-based data from Germany shows that BP in children and adolescents tracks only moderately
over six years. BP in childhood is the strongest independent predictor of future BP but its predictive value is limited.
1. Introduction
Blood pressure (BP) elevation is much more common among
children and adolescents than previously thought. Moreover,
BP in childhood correlates with BP in adulthood [1]; hence
children with elevated BP have a higher probability of
developing hypertension in adulthood than children with
lower BP. However, the usefulness of universal pediatric BP
screening is strongly debated due to the only moderate BP
tracking correlation from childhood to adulthood [1–4].
BP tracking correlation has two aspects: the stability of
BP ranking relative to others over a specified period of time
(calculated as tracking coefficients) and the predictability
of future values from baseline values. Meta-analyses have
reported moderate tracking coefficients of 0.42-0.38 for SBP
and 0.41-0.28 for DBP from childhood to adulthood [1, 3].
While several studies have investigated BP tracking in chil-
dren and adolescents and have compared different age groups
as well as BP tracking over different time periods, little is
known on whether having risk factors for hypertension, such
as overweight and obesity, low birthweight, or parental hyper-
tension, is associated with higher BP tracking correlation
from childhood to adolescence/young adulthood. Moreover,
the predictability of BP measurements from hypertension
risk factors in clinically meaningful terms such as positive
and negative predictive values has been reported only in the
context of screening, not of tracking [5].
Therefore, the aim of this study is twofold: (1) to investi-
gate six year BP tracking correlation coefficients from child-
hood to adolescence/young adulthood in a large population-
based sample with a broad baseline age range of 3 to 17 years
and to illustrate whether this aspect of tracking is stronger
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in subgroups with additional hypertension risk factors; and
(2) to analyse the predictability of future BP values above the
hypertension threshold from previous BP and hypertension
risk factors and to quantify this predictability using different
measures of association including odds ratios (OR) and
predictive values.
2. Methods
2.1. Study Population. The German Health Interview and
Examination Survey for Children and Adolescents (KiGGS)
is a nationwide study based on a stratified population-
registry sample of 17,641 participants aged 0–17 years living in
Germany (response rate 67%), including 14,835 participants
aged 3-17 years [6]. Details on the baseline and follow-up
surveys including its several parallel study modules were
published previously [6–8]. At baseline, about half of the
participants were invited to take part in the “Motorik Modul
Study” (MoMo; response rate 58%) [7]. The six-year MoMo
follow-up had a response rate of 48% [7]. The present anal-
ysis includes data from 2686 children and adolescents who
participated in the KiGGS baseline study KiGGS0 (t
0
2003-
2006; participants aged 3 to 17 years) and the MoMo follow-
up (t
1
2009-2012; participants aged 9 to 24 years) with com-
plete BP data sets and who have not taken antihypertensive
medication at t
0
(unfortunately we do not have information
on medication use at t
1
). The proportion of complete data
sets was higher for those 3-10 years old at t
0
than for those
11-17 years old. Analyses were stratified by age group: 3-10
years at t
0
and 9-17 years at t
1
vs. 11-17 years at t
0
and 18-24
years at t
1
. We therefore excluded 144 participants who did
not fall into these two groups in order to have a clear cutoff
in the age group analysis and not mix both hypertension
definitions (percentile and mmHg based; see below), leaving
2542 participants (1269 males and 1273 females) for analysis.
Additional follow-up data were available from the telephone
interview KiGGS1 2009-2012 [8].
BP measurement methods were standardized and fol-
lowed the same protocol in KiGGS0 2003-2006 (t
0
) and in
the MoMo study 2009-2012 (t
1
). At both time-points, BP
measurements were taken in the sitting position on a height-
adjustable chair with a backrest, the right forearm resting
on a table at the level of the heart, the elbow slightly bent,
the legs uncrossed, and the feet placed firmly on the floor.
Four cuff sizes (cuff bladder in cm 6 × 12, 9 × 18, 12 × 23,
or 17 × 38.6) were available, which had to cover at least
two-thirds of the upper arm length (from the axilla to the
antecubital fossa). Two readings of systolic (SBP), diastolic
blood pressure (DBP), mean arterial BP, and heart rate were
obtained at a two-minute interval with an automated upper
arm oscillometric device (DatascopeAccutorr Plus,Mahwah,
NJ) after a nonstrenuous part of the examination and an
additional 5-minute rest in both surveys [9, 10]. The mean
of the 2 systolic and diastolic measurements was used for this
analysis.
BP in children is age, gender, and height dependent;
therefore, it is not possible, as for adults, to designate a single
BP threshold to define hypertension. BP reference percentiles
[11] based on KiGGS data from nonoverweight children were
used according to German guidelines [12]: hypertensive BP
measurement was SBP or DBP at or above the 95th age-, sex-,
and height-specific percentile for children and adolescents
under 18 years, or BP ≥ 140/90 mmHg irrespective of the per-
centile. For young adults aged 18 years or older, the absolute
cutoff for hypertension (≥140/90 mmHg) was applied. Since
percentile-based cutoffs in children and the 140/90 mmHg
cutoff in adults are not equivalent, analyses were stratified
accordingly: baseline ages 3 to 10 years with t1-ages 9 to 17
years vs. baseline ages 11 to 17 years with t
1
-ages 18 to 24 years.
In addition, weight and height were measured at t
0
and
t
1
according to a common protocol. Weight was measured in
underwear to the nearest 0.1 kg with a calibrated scale (Seca,
Birmingham, United Kingdom) according to a standardized
protocol [6]. BMI was calculated as the ratio of weight (in
kg) by height2 (in m2) and rounded to 3 digits. BMI was
categorized as underweight, normal weight, overweight, and
obese according to the International Obesity Task Force
(IOTF) cutoffs defined by the age-specific percentiles in <18-
year olds, which at the age 18 and older correspond to the
adult cutoff points for overweight 25 kg/m2 and obesity 30
kg/m2 [13]. BMI trajectory was defined as the BMI course
between t
0
and t
1
in 4 categories: “persistently low or normal”
defined as under- or normal weight at t
0
and at t
1
; “resolution”
as overweight or obese at t
0
and normal or underweight at
t
1
; “persistently overweight/obesity” (at t
0
and at t
1
); and
“incident overweight/obesity” as under- or normal weight at
t
0
and overweight or obese at t
1
.
Information on physical activity was collected only in t
0
:
in children aged 3 to 10 years it was assessed through parent-
reported frequency of sports activities per week (categories: 3
ormore, 1-2, and less than once) [14] and in children aged 11 to
17 years through self-reported leisure time physical activities
that makes them sweat or get out of breath (categories: ≤2.0,
2.1-4.9, and 5.0-31.0 hours per week) [15].
Birth weight (in g) was reported by the mother at t
0
; we
have classified the variable into less than 2500 g, as low birth
weight, or greater than 2500 g.
Parental hypertension was collected at t
1
with the ques-
tion: has the mother or father of the study participant ever
been diagnosed by a doctor as having hypertension or high
blood pressure?
2.2. Statistical Analysis. The analysis was performed in two
parts. First, BP tracking was estimated by calculating Spear-
man’s rank-order correlation coefficients stratified by sex
and age and potential hypertension risk factors (over-
weight/obesity, birthweight and parental hypertension). For
this purpose, four age groups were chosen: 3 to 6, 7 to 10, 11
to 14, and 15 to 17 years. In the first two age groups, the rank
order of t
0
-percentiles was correlated with the rank order of
t
1
-percentiles. For the last two groups, the rank order of t
0
-
percentiles were correlated with the rank order of t
1
mmHg
values.
For testing statistical differences between correlation
coefficients, we have used the software cocor (http://compar-
ingcorrelations.org/) [16].
In the second part of the analysis, we determined the pro-
portion of participants with hypertensive BP measurement
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Table 1: Characteristics of the 2542 study participants (1269 males and 1273 females) at baseline (2003-2006) and at follow-up (2009-2012).
Males Females
Characteristics
Age range (years)
Baseline (t
0
)
(3-17)
Follow-up (t
1
)
(9-24) p-value
Baseline (t
0
)
(3-17)
Follow-up (t
1
)
(9-24) p-value
Mean age∗ 8.5(8.3-8.7)
14.7
(14.5-14.9) 0.000
8.5
(8.3-8.7)
14.8
(14.6-15.0) 0.000
SBP (mmHg)∗ 102.8(102.2-103.4)
117.6
(116.8-118.5) 0.000
102.8
(102.3-103.4)
114.7
(114.0-115.4) 0.000
DBP (mmHg)∗ 62.1(61.7-62.5)
66.2
(65.7-66.7) 0.001
62.7
(62.3-63.1)
66.0
(65.5-66.5) 0.001
Hypertensive BP& 8.5%(7.1-10.2)
15.7%
(13.8-17.8) 0.001
8.6%
(7.2-10.3)
14.0%
(12.2-16.0) 0.000
BMI (kg/m2)∗ 17.1(16.9-17.2)
20.7
(20.4-20.9) 0.000
17.1
(17.0-17.3)
20.5
(20.3-20.8) 0.000
Underweight 9.8%(8.3-11.6)
6.1%
(4.9-7.5) 0.001
11.3%
(9.7-13.2)
9.4%
(7.9-11.1) 0.104
Normal-weight 78.9%(76.6-81.1)
72.5%
(70.0-74.9) 0.000
74.0%
(71.6-76.4)
72.6%
(70.0-75.0) 0.372
Overweight 9.1%(7.6-10.8)
16.3%
(14.4-18.5) 0.000
12.2%
(10.5-14.1)
13.8%
(12.0-15.8) 0.238
Obese 2.2%(1.5-3.2)
5.1%
(4.0-6.5) 0.000
2.4%
(1.7-3.4)
4.3%
(3.3-5.5) 0.011
Sports activities (3 or more
times/week) (3-10 years)
43.2%
(40.1-46.4) - -
35.5%
(32.4-38.6) - -
Sports activities (h/week)∗
(11-17 years)
7.6
(6.5-8.8) - -
5.2
(4.7-5.7) - -
Parental hypertension - 28.1%(25.7-30.8) - -
30.3%
(27.7-32.9) -
Low birthweight
(<2500 g)
5.0%
(3.9-6.4) - -
6.3%
(5.1-7.8) - -
∗mean (95% CI).
&SBP or DBP at or above the 95th age-, sex-, and height-specific percentile for children and adolescents under 18 years, or BP ≥140/90 mmHg irrespective of
the percentile. For young adults aged 18 years or older, the absolute cutoffs for hypertension (≥140/90 mmHg) were applied.
at t
0
and t
1
. For calculating the positive predictive value
(PPV) of hypertensive BP at t
0
for future hypertensive BP (six
years later at t
1
), as well as the negative predictive value
(NPV) of normotensive BP at t
0
for future normotensive
BP,we used the softwareMedCalc (https://www.medcalc.org/
calc/diagnostic test.php). We calculated the PPV and NPV
also for risk factor combinations, e.g., for having hypertensive
BP and being obese at t
0
. In sensitivity analyses, we checked
whether the results were altered when using weighting factors
in the analysis. These weights take selective participation in
the MoMo study and the drop-out between t
0
and t
1
into
account. They are the inverse of the probability to participate
in the MoMo study/the follow-up, estimated in a logistic
regression model including several relevant KiGGS variables
as predictors. Since no weights are available for the exact
population under study here, we used three existing sets of
weights: longitudinal weights adjusting the KiGGS follow-
up to the KiGGS baseline, longitudinal weights adjusting the
MoMo follow-up to the MoMo baseline, and cross-sectional
MoMoweights adjusting the MoMo follow-up to the KiGGS1
follow-up.
Furthermore, we investigated the prediction of hyperten-
sive t
1
-BP from t
0
-BP and other baseline and follow-up risk
factors for hypertension, using logistic regression models.
Models were run separately for the t
0
-age-group 3 to 10 years
(percentile-defined t
1
-hypertension) and the t
0
-age-group 11
to 17 years (140/90mmHg threshold t
1
-hypertension). STATA
SE14.1 was used for the analyses.
3. Results
The characteristics of the 2542 study participants (1269 males
and 1273 females) at baseline (2003-2006) and six year follow-
up (2009-2012) are presented in Table 1. At six-year follow-
up, mean SBP had significantly increased by 14.8 mmHg
in males and by 11.9 mmHg in females. In addition, the
proportion of overweight in males and obesity in both sexes
was at follow-up statistically significantly greater compared
to baseline (Table 1).
Spearman rank-order correlations for BP tracking from
childhood to adolescence/young adulthood are shown in
Table 2. Tracking coefficients were higher for SBP (ranging
for sex-age groups from 0.33 to 0.50) than for DBP (ranging
for sex-age groups from 0.19 to 0.39). Although tracking
coefficients increased with age in males, this increase was not
statistically significant. Other differences between sex and age
groups were as well not statistically significant.
4 International Journal of Hypertension
Table 2: Spearman rank-order correlation coefficients for six year-tracking of BP in children and adolescents in Germany.
Baseline age n Tracking coefficients
SBP DBP
3-6 years1
All 1063 0.38 0.24
Male 530 0.33 0.19
Female 533 0.44 0.30
7-10 years1
All 953 0.42 0.36
Male 481 0.41 0.30
Female 472 0.42 0.42
11-14 years2
All 320 0.34 0.34
Male 155 0.43 0.32
Female 165 0.36 0.38
15-17 years2
All 206 0.47 0.36
Male 103 0.50 0.34
Female 103 0.46 0.39
1t0-BP and t1-BP in age-, sex-, and height-specific percentiles;
2t0-BP in percentiles and t1-BP in mmHg.
All Spearman rank-order¡sup/¿correlation coefficients were statistically significant at a p-value <0.001.
The BP tracking coefficients stratified by birthweight,
parental hypertension and BMI trajectories remained in the
order of magnitude of the tracking coefficients for the overall
sex-age groups; i.e., children with these hypertension risk
factors did not have substantially higher SBP or DBP tracking
correlation coefficients compared to children without these
risk factors (data not shown).
We investigated the prevalence of hypertensive BP mea-
surement at baseline and at follow-up in a younger age
group (baseline age 3 to 10 years, pediatric percentile-based
definition of hypertensive BP at t1) and an older age group
(baseline age 11 to 17 years, adult definition of hypertensive
BP at t
1
) (Figure 1). Among children aged 3 to 10 years, 7.9%
(95% CI 6.7-9.1) had hypertensive BP at baseline. Of these,
39% (n = 62 out of 159) also had hypertensive BP at follow-
up. The proportion of children with persistent hypertensive
BP (at t
0
and t
1
) accounted for 3.1% of this age group;
incident hypertensive BP (children with normal BP at t
0
and
hypertensive BP measurement at t
1
) was observed in 11.6%;
resolution of hypertensive BP (children with hypertensive BP
at t
0
and a normal BP at t
1
) was observed in 4.8% and the
proportion of persistently normal BP in the 3- to 10-year-old
group accounted for 80.5%. Among children and adolescents
aged 11 to 17 years, 11.2% (95% CI 8.6-14) had hypertensive
BP at baseline. Of these, 34% (n = 20 out of 59) also had
hypertensive BP at follow-up. In this age group, persistent
hypertensive BP accounted for 3.8%; incident hypertensive
BPwas observed in 12%; resolution of hypertensive BP in 7.4%
and persistently normal BP in 77% of the study population
(Figure 1).
The univariate and multivariable logistic regression
(Table 3) showed the factors associated with having hyper-
tensive BP at t1. In the models for both the younger and the
older age group hypertensive BP at t
0
was one of the major
determinants (OR 4.25 (95%CI 2.90-6.23) and OR 3.35 (95%
CI 1.60-7.01)). Further, increasing age was also identified as
a risk factor for hypertensive BP at follow-up in both age
groups. In the 3- to 10-year-old group, children with a per-
sistently overweight/obesity as well as those with an incident
overweight/obesity were more likely to have hypertensive
BP at t
1
(OR 2.70 (95% CI 1.78-4.12) and OR 4.44 (95%
CI 3.08-6.42), respectively) compared to children who had
a persistently low or normal BMI. A gender difference was
found only in the 11- to 17-year-old group, in which females
were less likely to have hypertensive BP at t
1
compared with
their male peers. Moreover, only in the 11- to 17-year-old
group, parental hypertension was found to be a determinant
for hypertensive BP at follow-up.
The probability of having hypertensive BP at six year
follow-up increasedwith baseline BP percentile (Figure 2) but
did not exceed 50%with the exception of a small subgroup (n
= 8) of 11- to 17-year-oldmales having a SBP between 90th and
94.9th percentile (prehypertensive at t
0
) with a probability of
88% (95% CI 47-99.7) of having hypertensive BP at t
1
.
The positive (PPV) and negative predictive values (NPV)
according to age at baseline and risk factors are presented in
Table 4.ThePPVof baseline hypertensive BP for hypertensive
BP six years later was 39% (95% CI 32-46) for 3- to 10-year-
old children and 34% (95% CI 24-45) for 11- to 17-year olds.
The NPV of non-hypertensive baseline BP was 87% (95%
CI 87-88) and 87% (95% CI 85-88) respectively. In the 3-
to 10-year-old group, the PPV increased as risk factors were
combined: for instance, 53% (95% CI 30-76) of 3- to 10-year-
old children with a hypertensive BP and obesity at baseline
also had hypertensive BP six years later. In the 11- to 17-year-
old group, similar probabilities of having hypertensive BP at
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Table 3: Predictors of hypertensive BP∗ at six-year follow-up in children and adolescents in Germany.
univariable analysis multivariable analysis
3- to 10-year-olds (at baseline) OR (95% CI) p-value OR (95% CI) p-value
Sex
Male Ref 0.50 Ref 0.19
Female 1.09 (0.85-1.39) 1.21 (0.91-1.59)
Age 1.14 (1.08-1.21) <0.001 1.15 (1.08-1.23) <0.001
BP t
0
normal (<P95) Ref <0.001 Ref <0.001
hypertensive (≥P95) 4.44 (3.14-6.28) 4.25 (2.90-6.23)
BMI trajectory (t
0
to t
1
)
persistently low or normal Ref <0.001 Ref <0.001
resolution 1.74 (0.96-3.16) 1.64 (0.86-3.11)
persistently overweight/obesity 3.87 (2.67-5.61) 2.70 (1.78-4.12)
incident overweight/obesity 3.95 (2.83-5.51) 4.44 (3.08-6.42)
Sport activities (times/week)
<1 Ref 0.14 Ref 0.07
1-2 1.21 (0.85-1.73) 1.30 (0.87-1.92)
≥3 1.42 (0.99-2.02) 1.58 (1.06-2.35)
Parental hypertension
No Ref 0.02 Ref 0.48
Yes 1.38 (1.06-1.80) 1.11 (0.83-1.49)
Low birthweight (<2500g)
No Ref 0.59 Ref 0.69
Yes 1.14 (0.70-1.88) 1.12 (0.64-1.96)
11- to 17-year-olds (at baseline)
Sex
Male Ref <0.001 Ref <0.001
Female 0.37 (0.22-0.61) 0.33 (0.18-0.61)
Age 1.22 (1.07-1.40) <0.01 1.21 (1.03-1.42) 0.02
BP t
0
normal (<P95) Ref <0.001 Ref 0.001
hypertensive (≥P95) 3.41 (1.87-6.23) 3.35 (1.60-7.01)
BMI trajectory (t
0
to t
1
)
persistently low or normal Ref 0.07 Ref 0.32
resolution 1.82 (0.58-5.70) 0.85 (0.17-4.19)
persistently overweight/obesity 2.23 (1.19-4.16) 1.96 (0.89-4.29)
incident overweight/obesity 1.50 (0.73-3.08) 1.59 (0.65-3.88)
Physical activities (hours/week)
≤2.0 Ref 0.24 Ref 0.42
2.1-4.9 1.76 (0.76-4.07) 1.75 (0.69-4.40)
5.0-31.0 1.93 (0.90-4.13) 1.70 (0.74-3.91)
Parental hypertension
No Ref 0.03 Ref 0.04
Yes 1.78 (1.07-2.95) 1.85 (1.02-3.33)
Low birthweight (<2500g)
No Ref 0.46 Ref 0.56
Yes 0.57 (0.13-2.50) 0.62 (0.12-3.16)
∗Hypertensive BP: SBP or DBP at or above the 95th age-, sex-, and height-specific percentile for children and adolescents under 18 years or BP ≥140/90 mmHg
irrespective of the percentile; for adults aged 18 or older: ≥140/90 mmHg.
OR = odds ratio BP = blood pressure.
6 International Journal of Hypertension
3-10 years old (at baseline) 9-17 years old (at follow-up)
Hypertensive mmHg≥140/90orpercentile≥DBPorSBPBP:
Hypertensive
BP 7.9%
Normal BP 
92.1%
Hypertensive
BP 14.7%
Normal BP 
85.3%
3.1%
80.6%
4.8%
11.
6%
95
ＮＢ
(a) Distribution of 2016 study participants at baseline (2003-2006) and
at follow-up (2009-2012) according to the BP measures
11-17 years old (at baseline) 18-24 years old (at follow-up)
Hypertensive BP at t 0 : mmHg≥140/90orpercentileDBPorSBP
Hypertensive BP at t 1 (≥18 year olds): ≥140/90 mmHg
Hypertensive
BP 11.2%
Normal BP 
88.8%
Hypertensive
BP 15.4%
Normal BP 
84.6%
3.8%
77.2%
7.4%
11.
6%
≥95ＮＢ
(b) Distribution of 526 study participants at baseline (2003-2006) and at
follow-up (2009-2012) according to the BP measures
Figure 1: Blood pressure in 2542 study participants at baseline (2003-2006) and at follow-up (2009-2012).
follow-up were observed in obese children at baseline (50%;
95%CI 27-74) and children with a hypertensive BP at baseline
and parental hypertension (48%; 95% CI 30-67) (Table 4).
4. Discussion
This study investigates different aspects of BP tracking
from childhood to adolescence/young adulthood with recent
population-based data from Germany. Applying various
metrics for assessing tracking including correlation coeffi-
cients, positive predictive values, and ORs from multivari-
able predictive modelling, BP tracking from childhood to
adolescence and young adulthood was generally moderate.
Our results confirm previous findings that BP in childhood
and adolescence is one of the strongest predictors of future
BP; however, it is one of the strongest predictors among
several moderate or weak predictors. Among children and
adolescents aged 3 to 17 yearswith hypertensive BP at baseline
(mean of two measurements taken on one occasion), about
one in three had hypertensive BP six years later. In population
subgroups of children with additional hypertension risk
factors such as overweight or parental hypertension, the PPV
of baseline hypertensive BP increased but was not much
higher than 50%.
In line with previous findings, we found moderate BP
tracking coefficients, higher for SBP than for DBP [1–3].
Stratified by age and sex, we found a SBP tracking correlation
in the range of 0.33 to 0.50 and for DBP in the range of 0.19
to 0.39, which was similar to the meta-analysis of Chen et al.
[1] who found a mean correlation coefficient of 0.38 for SBP
and of 0.28 for DBP.
One could ask whether BP tracking coefficients become
larger among children with additional risk factors for hyper-
tension, but in fact mathematically they are expected to
remain similar or even become smaller, as verified with
data from this study (results not shown). This happens since
in subgroups with additional hypertension risk factors, BP
values are more similar than in an unselected group and
International Journal of Hypertension 7
P0
-9
.9
P1
0-
19
.9
P2
0-
29
.9
P3
0-
39
.9
P4
0-
49
.9
P5
0-
59
.9
P6
0-
69
.9
P7
0-
79
.9
P8
0-
89
.9
P9
0-
94
.9
P9
5-
10
0
SBP Percentile at t0
Male
Female
P0
-9
.9
P1
0-
19
.9
P2
0-
29
.9
P3
0-
39
.9
P4
0-
49
.9
P5
0-
59
.9
P6
0-
69
.9
P7
0-
79
.9
P8
0-
89
.9
P9
0-
94
.9
P9
5-
10
0
DBP Percentile at t0
0
10
20
30
40
50
60
70
80
90
100
H
yp
er
te
ns
iv
e B
P 
at
 t1
 (%
)
0
10
20
30
40
50
60
70
80
90
100
H
yp
er
te
ns
iv
e B
P 
at
 t1
 (%
) 
Male
Female
3-10 years old at baseline
P0
-9
.9
P1
0-
19
.9
P2
0-
29
.9
P3
0-
39
.9
P4
0-
49
.9
P5
0-
59
.9
P6
0-
69
.9
P7
0-
79
.9
P8
0-
89
.9
P9
0-
94
.9
P9
5-
10
0
SBP Percentile at t0
P0
-9
.9
P1
0-
19
.9
P2
0-
29
.9
P3
0-
39
.9
P4
0-
49
.9
P5
0-
59
.9
P6
0-
69
.9
P7
0-
79
.9
P8
0-
89
.9
P9
0-
94
.9
P9
5-
10
0
H
yp
er
te
ns
iv
e B
P 
at
 t1
 (%
) 
DBP Percentile at t0
0
10
20
30
40
50
60
70
80
90
100
H
yp
er
te
ns
iv
e B
P 
at
 t1
 (%
) 
0
10
20
30
40
50
60
70
80
90
100
Male
Female
Male
Female
n=8 males having a SBP between 90th and 94.9th percentile at t0 with a probability of 88% (95% CI 47-99.7) of having hypertensive BP at t1
11-17 years old at baseline
Figure 2: Probability of having hypertensive BP at six year follow-up (t1) according to baseline BP percentiles.
ranking to a greater extent due to chance. In other words, for
combinations of risk factors, tracking coefficients are not an
appropriate measure for assessing the predictability of future
BP values.
Our results confirm previous findings that risk factors
for hypertensive BP in young adulthood can be identified in
childhood and adolescence [2, 17]. However, the associations
were moderate. After adjusting for various hypertension risk
factors including overweight/obesity and parental hyperten-
sion, a child aged 3 to 10 years with hypertensive BPwasmore
likely to have hypertensive BP six years later than a child in
the same age group with a normal BP (OR 4.25, 95% CI 2.90-
6.23). For the age group 11 to 17 years the respective adjusted
OR was 3.35 (95% CI 1.60-7.01).
The association between overweight/obesity and hyper-
tension in children was observed in several studies [18–20].
Our study showed that 36% of 3- to 10-year-old and 50% of
11- to 17 year-old obese children at baseline had a hypertensive
BP at follow-up.Themultivariable logistic regression analyses
revealed that 3- to 10-year-old participants with a persistently
or incidentally overweight/obesity were more likely to have a
hypertensive BP at follow-up compared to participants with
a persistently low or normal BMI trajectory, suggesting a
potential action for prevention of future hypertension. In this
regard, other studies have shown that children with higher
BMI at follow-up changed BP standard deviation scores from
initially normal to higher BP values [21]. Moreover, it has
been observed that changes in BMI during growth predicted
BP levels during adolescence [22]; for instance, the study of
Kelly et al. [2] showed that the resolution of elevated BP in
the transition from childhood to adulthood could be partially
explained by improvements in associated factors such as by
decreasing the BMI z-score between childhood and adult-
hood.
Our univariable logistic regression analysis showed that
children with hypertensive parents were at higher risk of
hypertension at follow-up compared to children without
hypertensive parents. However, this was only confirmed in
the multivariable analysis of 11-17-year olds. Children and
adolescents with parental hypertension had an 18% and
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Table 4: Positive (PPV) and negative predictive value (NPV) of various hypertension risk factors or risk factor combinations for hypertensive
BP∗ at six-year follow-up.
n Proportion at t
0
% (95% CI) PPV % (95% CI) NPV % (95% CI)
Baseline age 3 to 10 years
Hypertensive BP at t
0
2016 7.9 (6.8-9.1) 39 (32-46) 87 (87-88)
Overweight or obesity at t
0
2011 12 (11-14) 27 (22-32) 87 (86-88)
Obesity at t
0
2011 2.2 (1.7-3.0) 36 (23-50) 86 (85-86)
Parental hypertension 1942 29 (27-31) 18 (15-20) 87 (86-88)
Hypertensive BP and overweight or obesity at t
0
2011 2.0 (1.5-2.7) 48 (33-62) 86 (86-86)
Hypertensive BP and obesity at t
0
2011 0.7 (0.4-1.2) 53 (30-76) 86 (85-86)
Hypertensive BP at t
0
and parental hypertension 1942 2.6 (2.0-3.4) 51 (38-64) 86 (86-87)
Baseline age 11 to 17 years
Hypertensive BP at t
0
526 11 (8.8-14) 34 (24-45) 87 (85-88)
Overweight or obesity at t
0
525 17 (14-20) 24 (17-33) 87 (85-88)
Obesity at t
0
525 2.7 (1.6-4.5) 50 (27-74) 86 (85-87)
Parental hypertension 481 32 (28-36) 21 (16-26) 87 (85-89)
Hypertensive BP and overweight or obesity at t
0
525 3.2 (2.0-5.1) 35 (17-59) 85 (85-86)
Hypertensive BP and obesity at t
0
525 0.6 (0.2-1.8) § 85 (85-85)
Hypertensive BP at t
0
and parental hypertension 481 4.8 (3.2-7.1) 48 (30-67) 86 (85-87)
§n<=10 subjects
∗Hypertensive BP: SBP or DBP at or above the 95th age-, sex-, and height-specific percentile for children and adolescents under 18 years or BP ≥140/90 mmHg
irrespective of the percentile; for adults aged 18 or older: ≥140/90 mmHg.
21% probability of having a hypertensive BP at follow-up
(Table 4). A familial predisposition for hypertension was
reported in previous studies [23, 24]; furthermore, it has
been evaluated whether BP screening should target only
children with a parental hypertension instead of all children
(universal screening), with the conclusion that this may not
be a substantially better strategy [5].
In our data, obesity of the child/adolescent at t
0
was a
significantly stronger predictor for hypertension at t
1
than
parental hypertension in both age groups (Table 4).
Consistent with the literature [25–27] we observed male
sex as a risk factor for hypertension in young adults: Figure 2
showed that 11- to 17-year-old males at baseline had a higher
probability for having a hypertensive BP at follow-up (18 to
24 years) compared to females and Table 3 presented an OR
= 0.33 (95% CI 0.18-0.61) for 11- to 17-year-old females at
baseline, where they were less likely to have a hypertensive
BP at follow-up compared to their male peers.
Contrary to other reports [28, 29], our study did not
find a significant association between low birthweight and
hypertension.
Even though we did not find significant associations be-
tween physical activity at t
0
and hypertensive BP at follow-up,
our estimates showed the tendency of a negative correlation
between these two variables, which is in line with other
studies [30, 31].
Our study does not intend to estimate the prevalence of
hypertension in children, as the diagnosis of hypertension
requires, among other things, BP measurements on several
occasions; however, the proportion of children and adoles-
cents with persistently elevated BP in our study was 3.1%
for 3- to 10-year olds at baseline and 3.8% for 11- to 17-year
olds, which is in line with studies reporting prevalences of
sustained hypertension in children and adolescents of 1% to
5% [32–34].
Major strengths of this study are the large national
population database, coverage of a wide age range (3 to 17
years), the six-year follow-up, and standardized BP mea-
surements according to the same protocol at baseline and
follow-up examinations. However, despite using the same BP
measurement devices, identical resting times, and the same
measurement protocol, including performing BP measure-
ments before motor performance testing, we cannot exclude
the possibility that the environment and expectation of an
extensive motor testing like in the MoMo study could have
influenced BP at follow-up, leading to somewhat higher
BP values and somewhat lower tracking indices. Another
limitation is the possible selection bias arising from selective
participation in theMoMo study and from longitudinal drop-
out. Sensitivity analyses with weights that partially account
for this selection showed somewhat lower predictive values
and thus did not alter the main conclusions. A further
limitation is that the rule for KiGGS0 (2003-2006) was that
the cuff should cover at least two-thirds of the upper arm
length while current recommendations (2016 ESH guidelines
[4]) suggest that the cuff size should cover 80-100% of the
individual’s arm circumference. Another limitation is that we
had only two time points for assessment of the tracking; how-
ever, the KiGGS study just completed its second wave,
allowing a future analysis of BP trajectories over a 10-year
follow-up [35].
In conclusion, our analysis with recent population-based
data from Germany shows that BP in children and adoles-
cents tracks only moderately over six years; however, BP in
childhood is the strongest independent predictor for future
hypertensive BP measurements.
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